文献速递睡眠呼吸障碍

CPAP治疗睡眠呼吸暂停患者随访的新管理路径:数字医学与多模态远程监测

New management pathways for follow-up of CPAP-treated sleep apnoea patients including digital medicine and multimodal telemonitoring.
PubMed 文献 · Thorax · 2024-12-23

本文综述了数字医学和人工智能工具在CPAP治疗阻塞性睡眠呼吸暂停患者随访管理中的应用,重点讨论了患者表型分析、风险分层、远程监测路径及高危患者综合护理门诊的作用,并指出需根据具体表型调整远程随访的组成和程度,将数字与面对面随访适当结合。

要点

  • OSA具有异质性,不同表型对应不同CPAP依从性和预后,需多样化管理路径。
  • AI和机器学习可利用CPAP监测数据对患者进行风险分层并分配随访路径。
  • 远程CPAP监测已成为随访基石,但警报处理(如面罩更换和故障早期发现)需改进。

核心结论

  • 适当定制的数字与面对面CPAP随访相结合路径对OSA患者和医疗服务均有优势。

研究设计与样本

  • 本文为综述,聚焦CPAP治疗患者管理路径的重塑,特别关注远程监测平台,综述数字医学和人工智能工具在患者表型分析、分诊、风险分层及资源分配中的证据。

主要发现

  • OSA表型在症状、合并症、人口学、生活方式和社会经济背景方面存在差异,与不同CPAP依从模式和长期预后相关。
  • CPAP监测数据可利用AI和机器学习将患者分层至适当的随访管理路径。
  • 综合OSA护理门诊可为低依从性和合并症进展的高危患者提供多学科团队管理,包括合并症管理和连接可穿戴设备长期监测体力活动及远程CPAP监测。
  • 远程CPAP监测已成为随访基石,提供依从性和有效性信息,但警报处理(特别是面罩更换和CPAP故障早期发现)需改进。

临床怎么用

  • 根据OSA具体表型调整远程随访的程度和组成,远程监测不能完全替代面对面随访。
  • 利用AI和机器学习分析CPAP监测数据以进行风险分层和随访路径分配。
  • 高危患者(低依从性、合并症进展)可转至综合OSA护理门诊接受多学科管理。

局限性

  • CPAP监测的实施及其向多模态监测的扩展面临挑战(如数字护理的可及性)。
  • 某些患者表型(如OSA合并失眠)仅靠远程(甚至多模态)监测存在局限性,需要睡眠专家和/或其他学科同事的干预。
  • 远程管理路径替代面对面随访的利弊需考虑,包括一些国家需要重新评估CPAP设备报销政策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The ever-increasing number of patients diagnosed with obstructive sleep apnoea (OSA) and treated by long-term continuous positive airway pressure (CPAP) overstretches conventional follow-up pathways. New approaches to the management of CPAP-treated patient follow-up are needed to strike a balance between remote monitoring through digital technologies and in-person patient-healthcare-professional contacts. Focusing on the reshaping of the management of care pathways of CPAP-treated patients, with a specific focus on telemonitoring platforms, we aimed to review the evidence on how digital medicine and artificial intelligence (AI) tools are facilitating patient phenotyping and triage, risk stratification and the allocation of resources between the various healthcare professionals for an optimal follow-up of CPAP-treated patients. PHENOTYPING: OSA is a heterogeneous condition with diverse phenotypes differing in symptoms, comorbidities, demographics, lifestyle and socioeconomic context. Different phenotypes are associated with different CPAP adherence patterns and differing long-term prognosis. This diversity demands greater plurality in management pathways with different types and levels of support to ensure treatment adherence and risk reduction for patients while easing the burden on health services. In multidimensional phenotyping, we discuss alternatives to the apnoea hypopnoea index (AHI) as a measure of OSA severity. Then we consider risk stratification taking advantage of the wealth of CPAP monitoring data already available in databases that can now be exploited using AI and machine learning to direct (stratify) patients into appropriate follow-up management pathways. INTEGRATED CARE CLINICS FOR HIGH-RISK PATIENTS: We look at the role of integrated OSA care clinics particularly for the management of high-risk patients with low adherence and progression of comorbidities. Here, multidisciplinary teams might propose comorbidity management, and the use of connected wearable devices for long-term monitoring of physical activity, along with remote CPAP monitoring. REMOTE MANAGEMENT PATHWAYS: The pros and cons of remote management pathways to replace in-person follow-up visits are considered, including the need to re-evaluate CPAP-device reimbursement policies in some countries. While remote CPAP monitoring has become the cornerstone of follow-up providing information on adherence and efficacy, the processing of alerts needs to be improved, particularly regarding mask changes and early detection of CPAP failures. CHALLENGES: The implementation of CPAP monitoring alone, as well as its extension to multimodal monitoring, can present challenges that remain to be addressed (eg, access to digital care). The extent and components of remote follow-up must be adapted to each specific OSA phenotype. Finally, we give examples of certain patient phenotypes (eg, comorbid insomnia with OSA) with specific follow-up requirements, for which remote (even multimodal) monitoring alone has limitations and the intervention of both sleep specialists and/or their colleagues from other disciplines is needed. CONCLUSION: Appropriately tailored combined digital and in-person CPAP follow-up pathways would present advantages both for patients with OSA and healthcare services.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Pépin JL, Baillieul S, Bailly S, et al. New management pathways for follow-up of CPAP-treated sleep apnoea patients including digital medicine and multimodal telemonitoring. Thorax. 2024. PMID: 39667903. doi:10.1136/thorax-2024-221422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。